These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22564065)

  • 1. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES).
    McKetin R; Najman JM; Baker AL; Lubman DI; Dawe S; Ali R; Lee NK; Mattick RP; Mamun A
    Addiction; 2012 Nov; 107(11):1998-2008. PubMed ID: 22564065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study.
    McKetin R; Kothe A; Baker AL; Lee NK; Ross J; Lubman DI
    Drug Alcohol Rev; 2018 Jan; 37(1):70-78. PubMed ID: 28421682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
    Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
    Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of relapse on cognition in abstinent methamphetamine abusers.
    Simon SL; Dacey J; Glynn S; Rawson R; Ling W
    J Subst Abuse Treat; 2004 Jul; 27(1):59-66. PubMed ID: 15223095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users.
    Hillhouse MP; Marinelli-Casey P; Gonzales R; Ang A; Rawson RA;
    Addiction; 2007 Apr; 102 Suppl 1():84-95. PubMed ID: 17493057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Najman JM; Dawe S; Butterworth P; Baker AL
    Addiction; 2014 May; 109(5):798-806. PubMed ID: 24400972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
    J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes among women and men methamphetamine abusers in California.
    Hser YI; Evans E; Huang YC
    J Subst Abuse Treat; 2005 Jan; 28(1):77-85. PubMed ID: 15723735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planned duration of residential drug abuse treatment: efficacy versus effectiveness.
    McCusker J; Bigelow C; Vickers-Lahti M; Spotts D; Garfield F; Frost R
    Addiction; 1997 Nov; 92(11):1467-78. PubMed ID: 9519490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A preliminary study on outpatient relapse prevention program for methamphetamine dependent patients: Serigaya Methamphetamine Relapse Prevention Program (SMARPP)].
    Kobayashi O; Matsumoto T; Otsuki M; Endo K; Okudaira K; Harai H; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2007 Oct; 42(5):507-21. PubMed ID: 18051470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting.
    Rawson RA; Chudzynski J; Gonzales R; Mooney L; Dickerson D; Ang A; Dolezal B; Cooper CB
    J Subst Abuse Treat; 2015 Oct; 57():36-40. PubMed ID: 25934458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.